- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Elscint sells MRI scanner to Jordan
Israeli medical imaging vendor Elscint has won a contract to sellan MRI scanner to a Jordanian public hospital in a deal that isperhaps more important for its historic symbolism than its financialimpact. The system is the first sale of an Elscint MRI
Israeli medical imaging vendor Elscint has won a contract to sellan MRI scanner to a Jordanian public hospital in a deal that isperhaps more important for its historic symbolism than its financialimpact. The system is the first sale of an Elscint MRI scannerto an Arab country, according to Jonathan Adereth, president ofHaifa-based Elscint.
Israel and Jordan signed a peace agreement in 1994 that endedyears of hostility between the countries. The agreement also openedthe Jordanian market to Elscint's products, and in January thecompany won a deal from the Jordanian government to sell a 2-teslaPrestige scanner to Hospital El Bashir in Amman, beating out bidsfrom GE and Siemens.
Although the Arab market probably will not be a large one forElscint, the agreement is a breakthrough that represents the warmingpolitical and business ties between the nations.
"It was something more than just getting an order,"Adereth said. "It was a milestone on the march for establishingreal peace and relations between the countries."
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
